Koers Celsion Corporation Nasdaq
Aandelen
US15117N4043
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 13,26 mln. 12,16 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -21 mln. -19,27 mln. | Nettowinst (verlies) 2025 * | -25 mln. -22,94 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,67
x | K/w-verhouding 2025 * |
-0,86
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,85% |
Recentste transcriptie over Celsion Corporation
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 04-06-21 |
Michael Tardugno
CHM | Chairman | 73 | 03-01-07 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | 11/12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 56 | 08-06-21 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 08-07-11 |
James Dentzer
BRD | Director/Board Member | 57 | 03-09-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,17% | 126 mld. | |
+24,67% | 118 mld. | |
+25,04% | 27,87 mld. | |
-17,74% | 20,95 mld. | |
-15,17% | 16,92 mld. | |
-15,21% | 16,18 mld. | |
+11,91% | 14,84 mld. | |
-47,10% | 14,79 mld. | |
+54,50% | 14,08 mld. |
- Beurs
- Aandelen
- Koers IMNN
- Koers